HTRA2 and movement disorder: Additionally, the loss of function of Omi/HtrA2 is associated with increased ROS (Moisoi et al. 2009), mitochondrial dysfunction (Strauss et al. 2005) and a progressive movement disorder in mice (Jones et al. 2003; Rathke-Hartlieb et al. 2002).